Article
In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9.
Nature communications - 22 Dec 2020
Álvarez Beatriz, Mencía Mario, de Lorenzo Víctor, Fernández Luis Ángel
Abstract excerpt
In vivo mutagenesis systems accelerate directed protein evolution but often show restricted capabilities and deleterious off-site mutations on cells. To overcome these limitations, here we report an in vivo platform to diversify specific DNA segments based on protein fusions between various base deaminases (BD) and the T7 RNA polymerase (T7RNAP) that recognizes a cognate promoter oriented towards the target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
